Altered CD45 isoform expression in C77G carriers influences cytokine responsiveness and adhesion properties of T cells

Clinical and Experimental Immunology

Volumn 150, Issue 3, 2007, Pages 509-517

  Windhagen, A ^a   Sonmez D ^a   Hornig Do, H T ^a   Kalinowsky, A ^a   Schwinzer, R ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

C77G polymorphism; CD45; Multiple sclerosis; T cell reactivity

Indexed keywords

CD45 ANTIGEN; CYTOKINE; INTERLEUKIN 2; JANUS KINASE 1; T LYMPHOCYTE RECEPTOR;

ARTICLE; CELL ADHESION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE PREDISPOSITION; GENE OVEREXPRESSION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; NORMAL HUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; WILD TYPE;

ADULT; ANTIGENS, CD45; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HETEROZYGOTE; HUMANS; INTERLEUKIN-2; MIDDLE AGED; MONOCYTES; MULTIPLE SCLEROSIS; POLYMORPHISM, GENETIC; PROTEIN ISOFORMS; T-LYMPHOCYTES;

EID: 36048945330     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2007.03508.x     Document Type: Article

References (33)

1. Hermiston ML, Xu Z, Weiss A. CD45: a critical regulator of signaling thresholds in immune cells. Annu Rev Immunol 2003 21 : 107 37.
2. Irie-Sasaki J, Sasaki T, Matsumoto W et al. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. Nature 2001 409 : 349 54.
3. Shenoi H, Seavitt J, Zheleznyak A, Thomas ML, Brown EJ. Regulation of integrin-mediated T cell adhesion by the transmembrane protein tyrosine phosphatase CD45. J Immunol 1999 162 : 7120 7.
4. Streuli M, Hall LR, Saga Y, Schlossman SF, Saito H. Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens. J Exp Med 1987 166 : 1548 66.
5. Tchilian EZ, Beverley PC. Altered CD45 expression and disease. Trends Immunol 2006 27 : 146 53.
6. Boxall S, Stanton T, Hirai K et al. Disease associations and altered immune function in CD45 138G variant carriers. Hum Mol Genet 2004 13 : 2377 84.
7. Thude H, Hundrieser J, Wonigeit K, Schwinzer R. A point mutation in the human CD45 gene associated with defective splicing of exon A. Eur J Immunol 1995 25 : 2101 6.
8. Lynch KW, Weiss A. A CD45 polymorphism associated with multiple sclerosis disrupts an exonic splicing silencer. J Biol Chem 2001 276 : 24341 7.
9. Tchilian EZ, Dawes R, Ramaley PA et al. A CD45 polymorphism associated with abnormal splicing is absent in African populations. Immunogenetics 2002 53 : 980 3.
10. Jacobsen M, Schweer D, Ziegler A et al. A point mutation in PTPRC (CD45) is associated with the development of multiple sclerosis. Nat Genet 2000 26 : 495 9.
11. Ballerini C, Rosati E, Salvetti M et al. Protein tyrosine phosphatase receptor-type C exon 4 gene mutation distribution in an Italian multiple sclerosis population. Neurosci Lett 2002 328 : 325 7.
12. Vorechovsky I, Kralovicova J, Tchilian E et al. Does 77C→G in PTPRC modify autoimmune disorders linked to the major histocompatibility locus? Nat Genet 2001 29 : 22 4.
13. Barcellos LF, Caillier S, Dragone L et al. PTPRC (CD45) is not associated with the development of multiple sclerosis in U.S. patients. Nat Genet 2001 29 : 23 4.
14. Schwinzer R, Witte T, Hundrieser J et al. Enhanced frequency of a PTPRC (CD45) exon A mutation (77C→G) in systemic sclerosis. Genes Immun 2003 4 : 168 9.
15. Vogel A, Strassburg CP, Manns MP. 77 C/G mutation in the tyrosine phosphatase CD45 gene and autoimmune hepatitis: evidence for a genetic link. Genes Immun 2003 4 : 79 81.
16. Dawes R, Hennig B, Irving W et al. Altered CD45 expression in C77G carriers influences immune function and outcome of hepatitis C infection. J Med Genet 2006 43 : 678 84.
17. Tchilian EZ, Wallace DL, Dawes R et al. A point mutation in CD45 may be associated with an enhanced risk of HIV-1 infection. AIDS 2001 15 : 1892 4.
18. Boxall S, Mccormick J, Beverley P et al. Abnormal cell surface antigen expression in individuals with variant CD45 splicing and histiocytosis. Pediatr Res 2004 55 : 478 84.
19. Wood JP, Bieda K, Segni M et al. CD45 exon 4 point mutation does not confer susceptibility to type 1 diabetes mellitus or Graves' disease. Eur J Immunogenet 2002 29 : 73 4.
20. Thude H, Rosenhahn S, Hunger-Dathe W, Muller UA, Barz D. A transmembrane protein-tyrosine phosphatase receptor type C (CD45) exon A point mutation (77 C to G) is not associated with the development of type 1 diabetes mellitus in a German population. Eur J Immunogenet 2004 31 : 245 7.
21. Miterski B, Sindern E, Haupts M, Schimrigk S, Epplen J. PTPRC (CD45) is not associated with multiple sclerosis in a large cohort of German patients. BMC Med Genet 2002 3 : 3.
22. Esteghamat F, Noorinayer B, Sanati MH et al. C77G mutation in protein tyrosine phosphatase CD45 gene and autoimmune hepatitis. Hepatol Res 2005 32 : 154 7.
23. Do HT, Baars W, Borns K, Windhagen A, Schwinzer R. The 77C→G mutation in the human CD45 (PTPRC) gene leads to increased intensity of TCR signaling in T cell lines from healthy individuals and patients with multiple sclerosis. J Immunol 2006 176 : 931 8.
24. Wiesemann E, Sönmez D, Heidenreich F, Windhagen A. Interferon-β increases the stimulatory capacity of monocyte-derived dendritic cells to induce IL-13, IL-5, and IL-10 in autologous T-cells. J Neuroimmunol 2002 123 : 160 9.
25. Lorenz HM, Harrer T, Lagoo AS, Baur A, Eger G, Kalden JR. CD45 mAb induces cell adhesion in peripheral blood mononuclear cells via lymphocyte function-associated antigen-1 (LFA-1) and intercellular cell adhesion molecule 1 (ICAM-1). Cell Immunol 1993 147 : 110 28.
26. Piercy J, Petrova S, Tchilian EZ, Beverley PC. CD45 negatively regulates tumour necrosis factor and interleukin-6 production in dendritic cells. Immunology 2006 118 : 250 6.
27. Do HT, Baars W, Schwinzer R. Functional significance of the 77C→G polymorphism in the human CD45 gene: enhanced T-cell reactivity by variantly expressed CD45RA isoforms. Transplant Proc 2005 37 : 51 2.
28. Dawes R, Petrova S, Liu Z, Wraith D, Beverley PC, Tchilian EZ. Combinations of CD45 isoforms are crucial for immune function and disease. J Immunol 2006 176 : 3417 25.
29. Penninger JM, Irie-Sasaki J, Sasaki T, Oliveira-Dos-Santos AJ. CD45: new jobs for an old acquaintance. Nat Immunol 2001 2 : 389 96.
30. Petricoin EF 3rd, Ito S, Williams BL et al. Antiproliferative action of interferon-alpha requires components of T-cell-receptor signalling. Nature 1997 390 : 629 32.
31. Roach T, Slater S, Koval M et al. CD45 regulates Src family member kinase activity associated with macrophage integrin-mediated adhesion. Curr Biol 1997 7 : 408 17.
32. Herold C, Elhabazi A, Bismuth G, Bensussan A, Boumsell L. CD100 is associated with CD45 at the surface of human T lymphocytes. Role in T cell homotypic adhesion. J Immunol 1996 157 : 5262 8.
33. Arroyo AG, Campanero MR, Sanchez-Mateos P et al. Induction of tyrosine phosphorylation during ICAM-3 and LFA-1-mediated intercellular adhesion, and its regulation by the CD45 tyrosine phosphatase. J Cell Biol 1994 126 : 1277 86.